S

Salahuddin

Active Director Director DIN 01862877
DIN 01862877 First appointment Sep 1997 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 1997
Shareholding value •••• Premium profile

About Salahuddin

Data last updated:

Salahuddin is a Director at Esaren Pharmaceuticals Private Limited (since 1997). The company operates in Pharma. Esaren Pharmaceuticals Private Limited reported revenue of ₹57.8 Lakh (FY 2024).

DIN 01862877
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 1997
Oldest Company Age 29 yrs
Largest company Esaren Pharmaceuticals Private Limited · ₹57.8 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Sep 19971997₹57.8 Lakh (FY 2024)Active

Board colleagues of Salahuddin

NameDINCompanyDesignation
Khalda Khanam01229911Esaren Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Esaren Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Salahuddin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Salahuddin

Salahuddin currently holds 1 directorship: Esaren Pharmaceuticals Private Limited (Director, since 01 Sep 1997, revenue ₹57.8 Lakh (FY 2024)).

Salahuddin was first appointed on 01 Sep 1997 as Director at Esaren Pharmaceuticals Private Limited.

The current boards of Salahuddin's companies include Khalda Khanam (Esaren Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available